Arthur A. Daemmrich
There are 2 articles for this faculty member.
Where is the Pharmacy to the World? International Regulatory Variation and Pharmaceutical Industry Location
| Author: | Arthur Daemmrich |
|---|---|
| Published: | April 22, 2009 |
| Paper Release Date: | April 2009 |
| Feature: | Working Papers |
The era of paternalistic medicine has passed, but the notion that patients can act as consumers and make appropriate decisions concerning medical treatment poses countervailing risks of its own. A better accommodation among key players needs to be struck to foster the safe use of pharmaceuticals, according to HBS professor Arthur Daemmrich. The "pharmacy to the world," once located at the intersection of Germany, Switzerland, and France, today is found in the United States. Studies of the industry have attributed this sustained competitive advantage to a variety of factors, including U.S. intellectual property policies, funding for biomedical research through the National Institutes of Health, the absence of government controls on drug prices, and the availability of venture capital and other factors that fostered the growth of the biotechnology industry. The data and analysis presented in this working paper, however speculative, are an initial step toward deepening the understanding of interrelationships between government regulation, patients' mobilization both as regulators and as consumers, and the functioning of the pharmaceutical industry.
Published in 2007
The FDA: What Will the Next 100 Years Bring?
| Q&A with: | Arthur A. Daemmrich |
|---|---|
| Published: | September 24, 2007 |
| Feature: | Research & Ideas |
With the possible exception of the Internal Revenue Service, no other governmental agency touches the lives of more Americans than the U.S. Food and Drug Administration, which ensures the safety of $1.5 trillion worth of consumer goods and medicines. Harvard Business School professor Arthur A. Daemmrich discusses the impact and challenges of the agency and his new book, Perspectives on Risk and Regulation: The FDA at 100.
